Cargando…

Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis

We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months...

Descripción completa

Detalles Bibliográficos
Autores principales: Frenkel, Amit, Roy-Shapira, Aviel, Evgeni, Brotfain, Leonid, Koyfman, Borer, Abraham, Klein, Moti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
https://www.ncbi.nlm.nih.gov/pubmed/26257969
http://dx.doi.org/10.1155/2015/780824
_version_ 1782383511779409920
author Frenkel, Amit
Roy-Shapira, Aviel
Evgeni, Brotfain
Leonid, Koyfman
Borer, Abraham
Klein, Moti
author_facet Frenkel, Amit
Roy-Shapira, Aviel
Evgeni, Brotfain
Leonid, Koyfman
Borer, Abraham
Klein, Moti
author_sort Frenkel, Amit
collection PubMed
description We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship.
format Online
Article
Text
id pubmed-4519555
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45195552015-08-09 Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis Frenkel, Amit Roy-Shapira, Aviel Evgeni, Brotfain Leonid, Koyfman Borer, Abraham Klein, Moti Case Reports Immunol Case Report We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship. Hindawi Publishing Corporation 2015 2015-07-16 /pmc/articles/PMC4519555/ /pubmed/26257969 http://dx.doi.org/10.1155/2015/780824 Text en Copyright © 2015 Amit Frenkel et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Frenkel, Amit
Roy-Shapira, Aviel
Evgeni, Brotfain
Leonid, Koyfman
Borer, Abraham
Klein, Moti
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_full Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_fullStr Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_full_unstemmed Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_short Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_sort life threatening idiopathic recurrent angioedema responding to cannabis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
https://www.ncbi.nlm.nih.gov/pubmed/26257969
http://dx.doi.org/10.1155/2015/780824
work_keys_str_mv AT frenkelamit lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT royshapiraaviel lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT evgenibrotfain lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT leonidkoyfman lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT borerabraham lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT kleinmoti lifethreateningidiopathicrecurrentangioedemarespondingtocannabis